Risk of selection and timelines for the continued spread of artemisinin and partner drug resistance in Africa
Oliver J. Watson, Salome Muchiri, Abby Ward, Cecile Meier-Sherling, Victor Asua, Thomas Katairo, Tom Brewer, Gina Cuomo-Dannenburg, Peter Winskill, Jeffrey A Bailey, Lucy Okell, Graziella Scudu, Aaron M. Woolsey
doi: https://doi.org/10.1101/2024.08.28.24312699
Oliver J. Watson
1MRC Centre for Global Infectious Disease Analysis, Faculty of Medicine, Imperial College London, London, UK
Salome Muchiri
2Clinton Health Access Initiative, Boston, MA, 21127, USA
Abby Ward
2Clinton Health Access Initiative, Boston, MA, 21127, USA
Cecile Meier-Sherling
3Center for Computational Molecular Biology, Brown University, Providence, RI, USA
Victor Asua
4Infectious Diseases Research Collaboration, Kampala, Uganda
Thomas Katairo
4Infectious Diseases Research Collaboration, Kampala, Uganda
Tom Brewer
1MRC Centre for Global Infectious Disease Analysis, Faculty of Medicine, Imperial College London, London, UK
Gina Cuomo-Dannenburg
1MRC Centre for Global Infectious Disease Analysis, Faculty of Medicine, Imperial College London, London, UK
Peter Winskill
1MRC Centre for Global Infectious Disease Analysis, Faculty of Medicine, Imperial College London, London, UK
Jeffrey A Bailey
3Center for Computational Molecular Biology, Brown University, Providence, RI, USA
5Department of Pathology and Laboratory Medicine, Warren Alpert Medical School, Brown University, Providence, RI, USA
Lucy Okell
1MRC Centre for Global Infectious Disease Analysis, Faculty of Medicine, Imperial College London, London, UK
Graziella Scudu
2Clinton Health Access Initiative, Boston, MA, 21127, USA
Aaron M. Woolsey
2Clinton Health Access Initiative, Boston, MA, 21127, USA

Data Availability
All data, codes, and supplementary tables used and generated by this study are available in a Github Repository (version 1.0.1). All estimates of resistance spread are in the GitHub Repository.
Posted August 28, 2024.
Risk of selection and timelines for the continued spread of artemisinin and partner drug resistance in Africa
Oliver J. Watson, Salome Muchiri, Abby Ward, Cecile Meier-Sherling, Victor Asua, Thomas Katairo, Tom Brewer, Gina Cuomo-Dannenburg, Peter Winskill, Jeffrey A Bailey, Lucy Okell, Graziella Scudu, Aaron M. Woolsey
medRxiv 2024.08.28.24312699; doi: https://doi.org/10.1101/2024.08.28.24312699
Risk of selection and timelines for the continued spread of artemisinin and partner drug resistance in Africa
Oliver J. Watson, Salome Muchiri, Abby Ward, Cecile Meier-Sherling, Victor Asua, Thomas Katairo, Tom Brewer, Gina Cuomo-Dannenburg, Peter Winskill, Jeffrey A Bailey, Lucy Okell, Graziella Scudu, Aaron M. Woolsey
medRxiv 2024.08.28.24312699; doi: https://doi.org/10.1101/2024.08.28.24312699
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12228)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2657)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3882)
- Nursing (209)
- Nutrition (577)
- Oncology (2030)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6527)
- Radiology and Imaging (1403)
- Respiratory Medicine (871)
- Rheumatology (409)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)